What’s Buyable In Biotech After Recent Pullback?
The recent pullback in biotech “offers a chance to get into exciting areas of biotech research like gene editing and oncology at better prices.”
Biotech Stocks
With Biotech “Stronger Than Ever” In 2021, Here Are The 15 Fastest-Growing Biotech Companies In The U.S.
As a result of rising demand, artificial intelligence, increasing partnerships and scientific breakthroughs, Deloitte declared in a January report that the life sciences industry, including biotechnology, will be “stronger than ever” in 2021.
A Lucrative Opportunity At The $50 Billion Intersection Of Biotech And Cannabis
The company featured in today’s article finds itself at the intersection of biotech and cannabis – an intersection that could be worth $50 billion by 2029.
Is Biotech Acting More Than A Bit Like Bitcoin?
New Biotech World Order – surging share prices and booming initial public offerings of biotech stocks.
3 Reasons This Could Be “The Best Biotech Stock You Can Buy At The Moment”
Why might the stock highlighted in today’s article – shares of which have more than tripled investors’ money over the past year – be the… Read More »3 Reasons This Could Be “The Best Biotech Stock You Can Buy At The Moment”
3 Biotech Stocks To Watch – Including A Pioneering CBD Company
Among the three biotech stocks to watch going forward in 2021 highlighted by the author of today’s article is a specialty company focused on developing… Read More »3 Biotech Stocks To Watch – Including A Pioneering CBD Company
On The Cusp Of Commercializing Its First Drug, Now May Be The Time To Buy This Biotech Stock
When it comes to investing in biotech stocks, the author of today’s article points out that “By identifying companies that are likely to report rapid… Read More »On The Cusp Of Commercializing Its First Drug, Now May Be The Time To Buy This Biotech Stock
Biotech/Pharma Stocks To Watch In The First Days Of February
The final week of January was yet another big one for biotech, with perhaps the most important development of the week being phase III trial results for Novavax’s COVID-19 vaccine.
8 Biotech Stocks Facing FDA Decisions In February
As January comes to a close, which biotech stocks await FDA decisions in February that could serve as catalysts?
This Biotech Laggard Could Offer Traders A Market-Beating Opportunity
When it comes to the performance of healthcare companies during the pandemic, the author of today’s article notes that “Those best prepared for developing a… Read More »This Biotech Laggard Could Offer Traders A Market-Beating Opportunity